Recipient of federal assistance · SAN DIEGO, CA

VIVREON BIOSCIENCES LLC

VIVREON BIOSCIENCES LLC received $1.9M in federal grants and other assistance in FY2026, on 6 actions, −52% vs FY2025. It has no federal contracts in the loaded years. Since FY2021: $14.9M. Its largest awarding agency was National Institutes of Health ($1.9M).

Assistance · FY2026
$1.9M
New awards
0
Actions
6
Since FY2021
$14.9M
UEI
P935LHN98ZV9
Location
SAN DIEGO, CA
Businesses
Open in the explorerFederal grants & assistance

Federal grants & assistance received

Grants, loans (counted at their subsidy cost), direct payments and insurance, by fiscal year of the action (USAspending.gov, FABS). Reported apart from contracts and never added to them.

Assistance by fiscal year

  1. 500.4KFY2021
  2. 3.2MFY2022
  3. 1.9MFY2023
  4. 3.2MFY2024
  5. 4.1MFY2025
  6. 1.9MFY2026

By type

  1. Grants$1.9M100%

Top programs · Awarding agencies

Obligations in FY2026.

Top programs

  1. 93.866 · Aging Research$1.9M100%

Awarding agencies

  1. National Institutes of Health$1.9M100%
    Department of Health and Human Services

Largest awards

  1. PRECLINICAL CHARACTERIZATION OF CRAC CHANNEL INHIBITORS FOR THE TREATMENT OF ALZHEIMER'S DISEASE - VIVREON BIOSCIENCES, LLC 4940 CARROLL…$3.9M
    93.866 · Aging Research· National Institutes of Health· Project grant· Jun 20, 2025 – May 12, 2026· SB1AG087756
  2. DEVELOPMENT OF A NOVEL CALCIUM CHANNEL THERAPEUTIC FOR OPIOID USE DISORDER - VIVREON BIOSCIENCES, LLC 4940 CARROLL CANYON RD., STE. 110 SAN…$2.8M
    93.279 · Drug Use and Addiction Research Programs· National Institutes of Health· Project grant· Jul 6, 2023 – Jun 9, 2026· R44DA058467
  3. PRECLINICAL CHARACTERIZATION OF CRAC CHANNEL INHIBITORS FOR THE TREATMENT OF ALZHEIMER'S DISEASE - VIVREON BIOSCIENCES, LLC 4940 CARROLL…$2.5M
    93.866 · Aging Research· National Institutes of Health· Project grant· Sep 14, 2022 – Dec 2, 2025· R44AG061995
  4. PREDEVELOPMENT OF VV8220, A GUT-SELECTIVE CRAC CHANNEL THERAPEUTIC FOR ULCERATIVE COLITIS - VIVREON BIOSCIENCES, LLC 4940 CARROLL CANYON…$2M
    93.855 · Allergy and Infectious Diseases Research· National Institutes of Health· Project grant· Aug 1, 2024 – Jun 30, 2026· R44AI165096
  5. IND-ENABLING TOXICOLOGY FOR A NOVEL CA2+ CHANNEL THERAPEUTIC TO IMPROVE OUTCOMES ASSOCIATED WITH CHECKPOINT INHIBITOR IMMUNOTHERAPY…$1.9M
    93.395 · Cancer Treatment Research· National Institutes of Health· Project grant· May 31, 2022 – Apr 3, 2026· R44CA268541
  6. DEVELOPMENT OF A NOVEL CALCIUM CHANNEL THERAPEUTIC FOR DYSTROPHINOPATHIES - VIVREON BIOSCIENCES, LLC 4940 CARROLL CANYON RD. SUITE 110 SAN…$306.9K
    93.846 · Arthritis, Musculoskeletal and Skin Diseases Research· National Institutes of Health· Project grant· Aug 28, 2024 – Dec 3, 2025· R43AR083315

Source: Federal financial assistance transactions (Financial Assistance Broker Submission) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 8, 2026, loaded Oct 8, 2026 · FY2021–FY2026.